Xeris Biopharma Holdings (NASDAQ:XERS) will release Q1 2024 financial results on May 9.
A conference call and webcast at 8:30 a.m. Eastern Time will discuss financial and operational performance.
Pre-register for the call at https://www.netroadshow.com/events/login?show=7144015a&confId=62782.